Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells.

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells. — المؤلف: Mesti, Tanja — Radiology and oncology 20190930

المؤلف
Mesti, Tanja
النشر
Radiology and oncology 20190930
الوصف
392-398 p.
الموضوعات
Angiogenesis Inhibitors؛ Antibodies, Monoclonal, Humanized؛ Apoptosis؛ Bevacizumab؛ Biomarkers, Tumor؛ Brain Neoplasms؛ Cell Line, Tumor؛ Cell Survival